Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Tarsus Pharmaceuticals Inc (NASDAQ: TARS) was $50.30 for the day, down -3.10% from the previous closing price of $51.91. In other words, the price has decreased by -$3.10 from its previous closing price. On the day, 1.06 million shares were traded. TARS stock price reached its highest trading level at $53.89 during the session, while it also had its lowest trading level at $49.43.
Ratios:
Our analysis of TARS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.39 and its Current Ratio is at 4.42. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 20, 2023, initiated with a Neutral rating and assigned the stock a target price of $19.
On July 18, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $44.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when Azamian Bobak R. sold 6,000 shares for $50.00 per share. The transaction valued at 300,000 led to the insider holds 824,106 shares of the business.
Azamian Bobak R. bought 6,000 shares of TARS for $300,000 on Mar 24 ’25. On Mar 18 ’25, another insider, Mottiwala Aziz, who serves as the Chief Commercial Officer of the company, sold 3,643 shares for $46.29 each. As a result, the insider received 168,634 and left with 71,979 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARS now has a Market Capitalization of 2112952064 and an Enterprise Value of 1711449088. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.55 while its Price-to-Book (P/B) ratio in mrq is 8.59. Its current Enterprise Value per Revenue stands at 9.355 whereas that against EBITDA is -14.34.
Stock Price History:
The Beta on a monthly basis for TARS is 0.94, which has changed by 0.3649932 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, TARS has reached a high of $57.28, while it has fallen to a 52-week low of $20.08. The 50-Day Moving Average of the stock is 5.08%, while the 200-Day Moving Average is calculated to be 18.92%.
Shares Statistics:
TARS traded an average of 657.12K shares per day over the past three months and 730280 shares per day over the past ten days. A total of 38.35M shares are outstanding, with a floating share count of 35.81M. Insiders hold about 13.92% of the company’s shares, while institutions hold 94.57% stake in the company. Shares short for TARS as of 1744675200 were 8378489 with a Short Ratio of 12.75, compared to 1741910400 on 7403040. Therefore, it implies a Short% of Shares Outstanding of 8378489 and a Short% of Float of 20.809999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
